Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
JAMA Oncology
|
April 17, 2025
Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Nonrandomized Clinical Trial
Mingming Zhang, Shan Fu, Jingjing Feng, et al.
Leukemia
|
May 22, 2019
CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
Jing Pan, Qing Niu, Biping Deng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2023
Anti-G Protein-Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma: A Single-Arm, Phase Ⅱ Trial
Jieyun Xia, Hujun Li, Zhiling Yan, et al.
The New England Journal of Medicine
|
April 24, 2024
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis
Yongxian Hu, Mingming Zhang, Tingting Yang, et al.
The Lancet. Haematology
|
April 14, 2025
Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm, phase 2 trial
Jieyun Xia, Qian Sun, Dian Zhou, et al.
Molecular Oncology
|
February 22, 2025
Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancer
Marina N Sharifi, Eric Feng, Nicholas R Rydzewski, et al.
Journal of Hematology & Oncology
|
May 6, 2020
Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study
Houli Zhao, Jieping Wei, Guoqing Wei, et al.
American Journal of Hematology
|
May 14, 2026
Pre-Transplant MRD Negativity and Age Under 40 Predict Superior Long-Term Survival in Relapsed/Refractory B-ALL After CAR-T Therapy Bridging to Haploidentical HSCT: A Multicenter Retrospective Study With 6-Year Follow-Up
Houli Zhao, Zhouning Lin, Haiqiong Zheng, et al.
The New England Journal of Medicine
|
January 14, 2026
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
Ruonan Li, Hong Pan, Lele Zhang, et al.
Cancer Discovery
|
April 1, 2025
High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes
Marina N Sharifi, Jamie M Sperger, Amy K Taylor, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
JAMA Oncology
|
April 17, 2025
Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Nonrandomized Clinical Trial
Mingming Zhang, Shan Fu, Jingjing Feng, et al.
Leukemia
|
May 22, 2019
CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
Jing Pan, Qing Niu, Biping Deng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2023
Anti-G Protein-Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma: A Single-Arm, Phase Ⅱ Trial
Jieyun Xia, Hujun Li, Zhiling Yan, et al.
The New England Journal of Medicine
|
April 24, 2024
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis
Yongxian Hu, Mingming Zhang, Tingting Yang, et al.
The Lancet. Haematology
|
April 14, 2025
Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm, phase 2 trial
Jieyun Xia, Qian Sun, Dian Zhou, et al.
Molecular Oncology
|
February 22, 2025
Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancer
Marina N Sharifi, Eric Feng, Nicholas R Rydzewski, et al.
Journal of Hematology & Oncology
|
May 6, 2020
Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study
Houli Zhao, Jieping Wei, Guoqing Wei, et al.
American Journal of Hematology
|
May 14, 2026
Pre-Transplant MRD Negativity and Age Under 40 Predict Superior Long-Term Survival in Relapsed/Refractory B-ALL After CAR-T Therapy Bridging to Haploidentical HSCT: A Multicenter Retrospective Study With 6-Year Follow-Up
Houli Zhao, Zhouning Lin, Haiqiong Zheng, et al.
The New England Journal of Medicine
|
January 14, 2026
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
Ruonan Li, Hong Pan, Lele Zhang, et al.
Cancer Discovery
|
April 1, 2025
High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes
Marina N Sharifi, Jamie M Sperger, Amy K Taylor, et al.
Page
of 8